{"id":7985,"date":"2025-07-19T17:31:04","date_gmt":"2025-07-19T14:31:04","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=7985"},"modified":"2025-07-19T17:31:04","modified_gmt":"2025-07-19T14:31:04","slug":"clinical-summary-scai-2025-guidelines-for-chronic-venous-disease-cvd","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/clinical-summary-scai-2025-guidelines-for-chronic-venous-disease-cvd\/","title":{"rendered":"Clinical Summary: SCAI 2025 Guidelines for Chronic Venous Disease (CVD)"},"content":{"rendered":"
Clinical Summary: SCAI 2025 Guidelines for Chronic Venous Disease (CVD)<\/div>\n
<\/div>\n
Published: July 1, 2025 | Source: SCAI \u2013 Society for Cardiovascular Angiography and Interventions<\/div>\n
<\/div>\n
1. Presidential Context<\/div>\n
\u2022 Former U.S. President Donald Trump (age 79) was recently diagnosed with chronic venous insufficiency (CVI) after presenting with leg swelling.<\/span><\/div>\n
\u2022 Bilateral Doppler ultrasound confirmed CVI; no signs of DVT or arterial disease.<\/span><\/div>\n
\u2022 Echocardiography showed normal cardiac function, with no evidence of heart failure.<\/span><\/div>\n
\u2022 The case highlighted CVI as a common but generally benign condition, especially in older adults.<\/span><\/div>\n
<\/div>\n
2. Disease Overview<\/div>\n
\u2022 CVD results from failure of leg veins to efficiently return blood to the heart.<\/span><\/div>\n
\u2022 Over 25 million adults in the U.S. are affected, with prevalence increasing significantly after age 70.<\/span><\/div>\n
\u2022 Symptoms include leg heaviness, ankle swelling, skin discoloration, and in advanced cases, venous ulcers.\u00a0<\/span><\/div>\n
<\/div>\n
3. SCAI 2025: General Guideline Framework<\/div>\n
\u2022 Developed using the GRADE methodology.<\/span><\/div>\n
\u2022 Endorsed by the Society for Vascular Medicine.<\/span><\/div>\n
\u2022 Includes 8 key clinical recommendations based on randomized trials and expert consensus.<\/span><\/div>\n
\u2022 Emphasizes a patient-centered approach and shared decision-making.<\/span><\/div>\n
\u2022 Future updates expected between 2\u20135 years post-publication.<\/span><\/div>\n
<\/div>\n
4. Treatment Recommendations by Modality<\/div>\n
<\/div>\n
\u00a0 \u00a04.1 Compression Therapy<\/div>\n
\u2022 Strongly recommended for patients with venous ulcers.<\/span><\/div>\n
\u2022 Conditionally recommended for patients with symptomatic varicose veins.<\/span><\/div>\n
\u2022 Benefits include reduced edema, pain, and improved ulcer healing.<\/span><\/div>\n
\u2022 Limitations: adherence may be low due to discomfort or difficulty donning stockings.<\/span><\/div>\n
<\/div>\n
\u00a0 \u00a0 4.2 Ablation Therapy<\/div>\n
\u2022 Conditionally recommended for patients with reflux in the great saphenous vein (GSV), small saphenous vein (SSV), or accessory GSV.<\/span><\/div>\n
\u2022 Especially useful when conservative therapy fails or ulcers are present.<\/span><\/div>\n
\u2022 Improves symptom control and ulcer healing.<\/span><\/div>\n
\u2022 Nonthermal techniques are preferred below the knee to reduce nerve injury.<\/span><\/div>\n
<\/div>\n
\u00a0 \u00a0 \u00a04.3 Foam Sclerotherapy<\/div>\n
\u2022 Conditionally recommended for:<\/span><\/div>\n
\u2022 Symptomatic varicose veins without truncal reflux.<\/span><\/div>\n
\u2022 Nonhealing ulcers resistant to compression therapy.<\/span><\/div>\n
\u2022 Benefits include symptom relief and cosmetic improvement.<\/span><\/div>\n
\u2022 Small risks: DVT, skin pigmentation, and phlebitis.<\/span><\/div>\n
<\/div>\n
\u00a0 \u00a0 \u00a04.4 Phlebectomy<\/div>\n
\u2022 Conditionally recommended for symptomatic varicose veins without truncal reflux or after failed ablation.<\/span><\/div>\n
\u2022 Associated with faster symptom resolution and lower recurrence rates.<\/span><\/div>\n
\u2022 No recommendation for venous ulcers due to insufficient evidence.<\/span><\/div>\n
<\/div>\n
\u00a0 \u00a0 \u00a04.5 Iliocaval Stenting<\/div>\n
\u2022 Conditionally recommended in patients with severe iliac vein obstruction (e.g., May-Thurner syndrome) and persistent symptoms despite compression.<\/span><\/div>\n
\u2022 Improves quality of life and wound healing.<\/span><\/div>\n
\u2022 Requires intravascular ultrasound (IVUS) for accurate sizing.<\/span><\/div>\n
\u2022 Risk of stent migration or restenosis if improperly placed.<\/span><\/div>\n
<\/div>\n
\u00a0 \u00a0 \u00a04.6 Femoral or Common Femoral Vein Stenting<\/div>\n
\u2022 No recommendation given due to lack of adequate evidence.<\/span><\/div>\n
\u2022 Identified as a knowledge gap in the field.<\/span><\/div>\n
\u2022 Future research needed for post-thrombotic patients with isolated femoral disease.<\/span><\/div>\n
<\/div>\n
5. Summary of Clinical Approach<\/div>\n
\u2022 Start with compression therapy in nearly all patients.<\/span><\/div>\n
\u2022 Add ablation when there is saphenous reflux or poor response.<\/span><\/div>\n
\u2022 Use sclerotherapy or phlebectomy in selected cases based on anatomy and patient preference.<\/span><\/div>\n
\u2022 Reserve iliocaval stenting for advanced, obstructive disease.<\/span><\/div>\n
\u2022 Avoid deep venous interventions unless supported by strong imaging and clinical need.<\/span><\/div>\n
<\/div>\n
6. Final Note<\/div>\n
<\/div>\n
These are the first comprehensive venous guidelines from SCAI, offering interventional cardiologists and vascular specialists a structured, evidence-informed roadmap for treating chronic venous disorders. As venous procedures continue to increase globally, standardized guidance is essential to improve outcomes and access to care.<\/div>\n
]<\/div>\n
<\/div>\n
\ud83d\udd17 Full Document Link:<\/div>\n
http:\/\/www.scai.org\/guidelines\/chronic-venous-disease-2025<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"

Clinical Summary: SCAI 2025 Guidelines for Chronic Venous Disease (CVD) Published: July 1, 2025 | Source: SCAI \u2013 Society for Cardiovascular Angiography and Interventions 1. Presidential Context \u2022 Former U.S. President Donald Trump (age 79) was recently diagnosed with chronic venous insufficiency (CVI) after presenting with leg swelling. \u2022 Bilateral Doppler ultrasound confirmed CVI; no […]<\/p>\n","protected":false},"author":145,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7985","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/145"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=7985"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7985\/revisions"}],"predecessor-version":[{"id":7986,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/7985\/revisions\/7986"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=7985"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=7985"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=7985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}